Advanced Pancreatic Cancer: A Phase I-II Trial of Cisplatin, High-Dose Cytarabine, and Caffeine
In a phase I-II study, 28 patients with advanced pancreatic adenocarcinoma were treated with cisplatin, high-dose cytarabine (ARA-C), and caffeine. This clinical trial was based...